Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories Issues FY 2013 EPS Guidance


Wednesday, 23 Jan 2013 07:00am EST 

Abbott Laboratories announced that it is issuing ongoing earnings-per-share guidance for fiscal 2013 of $1.98 to $2.04. The Company forecasts net specified items for fiscal 2013 of approximately $0.59 per share, primarily associated with intangible amortization expense, separation costs and cost-reduction initiatives. Including these net specified items, projected earnings per share under Generally Accepted Accounting Principles (GAAP) would be $1.39 to $1.45 for fiscal 2013. 

Company Quote

43.38
0.48 +1.12%
17 Sep 2014